Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, October 15, 2021
[ Fri, Oct 15th 2021
] - WOPRAI
[ Fri, Oct 15th 2021
] - WOPRAI
[ Fri, Oct 15th 2021
] - WOPRAI
[ Fri, Oct 15th 2021
] - WOPRAI
[ Fri, Oct 15th 2021
] - WOPRAI
[ Fri, Oct 15th 2021
] - WOPRAI
[ Fri, Oct 15th 2021
] - WOPRAI
[ Fri, Oct 15th 2021
] - WOPRAI
[ Fri, Oct 15th 2021
] - WOPRAI
[ Fri, Oct 15th 2021
] - WOPRAI
[ Fri, Oct 15th 2021
] - WOPRAI
[ Fri, Oct 15th 2021
] - WOPRAI
[ Fri, Oct 15th 2021
] - WOPRAI
[ Fri, Oct 15th 2021
] - WOPRAI
[ Fri, Oct 15th 2021
] - WOPRAI
[ Fri, Oct 15th 2021
] - WOPRAI
[ Fri, Oct 15th 2021
] - WOPRAI
[ Fri, Oct 15th 2021
] - WOPRAI
[ Fri, Oct 15th 2021
] - WOPRAI
[ Fri, Oct 15th 2021
] - WOPRAI
[ Fri, Oct 15th 2021
] - WOPRAI
[ Fri, Oct 15th 2021
] - WOPRAI
[ Fri, Oct 15th 2021
] - WOPRAI
[ Fri, Oct 15th 2021
] - WOPRAI
[ Fri, Oct 15th 2021
] - WOPRAI
[ Fri, Oct 15th 2021
] - WOPRAI
William Plovanic Upgraded (ANGO) to Strong Buy and Increased Target to $37 on, Oct 15th, 2021
William Plovanic of Canaccord Genuity, Upgraded "AngioDynamics, Inc." (ANGO) to Strong Buy and Increased Target from $28 to $37 on, Oct 15th, 2021.
William has made no other calls on ANGO in the last 4 months.
There are 3 other peers that have a rating on ANGO. Out of the 3 peers that are also analyzing ANGO, 2 agree with William's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Steven Lichtman of "Oppenheimer" Initiated at Hold on, Friday, August 20th, 2021
- Jason Mills of "Canaccord Genuity" Maintained at Hold with Increased Target to $28 on, Wednesday, July 14th, 2021
This is the rating of the analyst that currently disagrees with William
- Jayson Bedford of "Raymond James" Maintained at Strong Buy with Increased Target to $32 on, Friday, July 9th, 2021
